These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 2565392

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Beta-2-adrenoceptor-mediated hypokalemia and its abolishment by oxprenolol.
    Jonkers R, Van Boxtel CJ, Oosterhuis B.
    Clin Pharmacol Ther; 1987 Dec; 42(6):627-33. PubMed ID: 2826064
    [Abstract] [Full Text] [Related]

  • 4. Quantification of metoprolol beta 2-adrenoceptor antagonism in asthmatic patients by pharmacokinetic-pharmacodynamic modelling.
    Braat MC, Jonkers RE, van Boxtel CJ.
    Pulm Pharmacol; 1992 Dec; 5(1):31-8. PubMed ID: 1591462
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ, High J, DeForrest JM, Sybertz E.
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [Abstract] [Full Text] [Related]

  • 7. Effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents.
    Schneider RE, Bishop H, Kendall MJ, Quarterman CP.
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):158-62. PubMed ID: 6114930
    [Abstract] [Full Text] [Related]

  • 8. Modeling the metabolic effects of terbutaline in beta2-adrenergic receptor diplotypes.
    Lima JJ, Matsushima N, Kissoon N, Wang J, Sylvester JE, Jusko WJ.
    Clin Pharmacol Ther; 2004 Jul; 76(1):27-37. PubMed ID: 15229461
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Receptor binding characteristics and pharmacokinetic properties as a tool for the prediction of clinical effects of beta-blockers.
    Wellstein A, Palm D, Belz GG, Pitschner HF.
    Arzneimittelforschung; 1985 Jul; 35(1):2-6. PubMed ID: 2859024
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Is metoprolol CR/ZOK more selective than conventional metoprolol and atenolol?
    Kendall M, Akhlaghi S, Hughes B, Lewis H.
    J Clin Pharmacol; 1990 Feb; 30(S2):S98-102. PubMed ID: 2155948
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.